
Halle C. F. Moore, MD
Advertisement
Articles by Halle C. F. Moore, MD


This video reviews a meta-analysis that looked at five studies testing the use of a gonadotropin-releasing hormone (GnRH) analog to protect ovarian function and preserve fertility in premenopausal women undergoing chemotherapy for early-stage breast cancer.

This review will focus largely on the effects of systemic cytotoxic treatment on cognitive function, reflecting what has been most extensively studied in the literature.
Advertisement
Latest Updated Articles
An Overview of Chemotherapy-Related Cognitive Dysfunction, or ‘Chemobrain’September 15th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Camizestrant for ESR1-Mutated HR+/HER2– Advanced Breast Cancer
2
How Do Final CAPItello-291 OS Data Shape Capivasertib Use in Breast Cancer?
3
Managing High-Risk BCLC-C HCC in a Younger Fit Patient
4
AI's Evolving Role in Radiation Oncology
5
